FY22 Drug Recalls Highest in Five Years: FDA Report

In fiscal year 2022, the FDA recorded a notable increase in registered manufacturing sites, as well as a spike in product recalls, warning letters issued and surveillance inspections, according to the regulator’s annual Report on the State of Pharmaceutical Quality.